{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:05:50Z","timestamp":1765728350541},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.bone.2008.09.006","type":"journal-article","created":{"date-parts":[[2008,9,27]],"date-time":"2008-09-27T08:41:14Z","timestamp":1222504874000},"page":"153-159","source":"Crossref","is-referenced-by-count":39,"title":["Effectiveness of bisphosphonate therapy in a community setting"],"prefix":"10.1016","volume":"44","author":[{"given":"Adrianne C.","family":"Feldstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Weycker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerry","family":"Oster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Boardman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2008.09.006_bib1","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2008.09.006_bib2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005\u20132025","volume":"22","author":"Burge","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2008.09.006_bib3","first-page":"921","article-title":"Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 1. Introduction","volume":"155","author":"Hanley","year":"1996","journal-title":"CMAJ"},{"key":"10.1016\/j.bone.2008.09.006_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.ogx.0000197807.08697.06","article-title":"Fracture prevention in postmenopausal osteoporosis: a review of treatment options","volume":"61","author":"McCarus","year":"2006","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.bone.2008.09.006_bib5","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2008.09.006_bib6","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2008.09.006_bib7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/er.2001-9002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bone.2008.09.006_bib8","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s00198-005-1945-x","article-title":"Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies","volume":"16","author":"Boonen","year":"2005","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2008.09.006_bib9","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2008.09.006_bib10","doi-asserted-by":"crossref","first-page":"488","DOI":"10.18553\/jmcp.1998.4.5.488","article-title":"Alendronate use among 812 women: prevalence of gastrointestinal complaints, non-compliance with patient instructions, and discontinuation","volume":"4","author":"Ettinger","year":"1998","journal-title":"J. Manag. Care Pharm."},{"key":"10.1016\/j.bone.2008.09.006_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.maturitas.2004.02.005","article-title":"Compliance with drug therapies for the treatment and prevention of osteoporosis","volume":"48","author":"McCombs","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.bone.2008.09.006_bib12","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4065\/81.8.1013","article-title":"Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases","volume":"81","author":"Siris","year":"2006","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bone.2008.09.006_bib13","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s00198-006-0179-x","article-title":"Compliance with drug therapy for postmenopausal osteoporosis","volume":"17","author":"Weycker","year":"2006","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2008.09.006_bib14","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.bone.2005.10.022","article-title":"Assessment of compliance with osteoporosis treatment and its consequences in a managed care population","volume":"38","author":"Huybrechts","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2008.09.006_bib15","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00198-004-1652-z","article-title":"The impact of compliance with osteoporosis therapy on fracture rates in actual practice","volume":"15","author":"Caro","year":"2004","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2008.09.006_bib16","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1359\/jbmr.060715","article-title":"Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study","volume":"21","author":"Adami","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2008.09.006_bib17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00198-006-0230-y","article-title":"Compliance with osteoporosis drug therapy and risk of fracture","volume":"18","author":"Weycker","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2008.09.006_bib18","series-title":"Promise and performance in managed care: the prepaid group practice model","author":"Freeborn","year":"1994"},{"key":"10.1016\/j.bone.2008.09.006_bib19","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1001\/archinte.163.18.2165","article-title":"Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline","volume":"163","author":"Feldstein","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bone.2008.09.006_bib20","series-title":"Physicians guide to prevention and treatment of osteoporosis","year":"2000"},{"key":"10.1016\/j.bone.2008.09.006_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S8756-3282(02)00788-3","article-title":"Secondary osteoporosis and the risk of distal forearm fractures in men and women","volume":"31","author":"Melton","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.bone.2008.09.006_bib22","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2008.09.006_bib23","doi-asserted-by":"crossref","first-page":"837","DOI":"10.7326\/0003-4819-115-11-837","article-title":"Which fractures are associated with low appendicular bone mass in elderly women? The Study of Osteoporotic Fractures Research Group","volume":"115","author":"Seeley","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bone.2008.09.006_bib24","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM199503233321202","article-title":"Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group","volume":"332","author":"Cummings","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2008.09.006_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1517\/14740338.7.1.69","article-title":"Effect of thiazolidinediones on skeletal health in women with Type 2 diabetes","volume":"7","author":"Schwartz","year":"2008","journal-title":"Expert. Opin. Drug Saf."},{"key":"10.1016\/j.bone.2008.09.006_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11914-007-0008-y","article-title":"Medication-induced osteoporosis","volume":"5","author":"Weng","year":"2007","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.bone.2008.09.006_bib27","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/BOR.0b013e3282ff0d6d","article-title":"Incidence and prevalence of medication-induced osteoporosis: evidence-based review","volume":"20","author":"Allport","year":"2008","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.bone.2008.09.006_bib28","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1056\/NEJM198812293192604","article-title":"Risk factors for falls among elderly persons living in the community","volume":"319","author":"Tinetti","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2008.09.006_bib29","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMsa003087","article-title":"Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors","volume":"346","author":"Schneeweiss","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2008.09.006_bib30","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00198-007-0550-6","article-title":"Cost-effective osteoporosis treatment thresholds: the United States perspective","volume":"19","author":"Tosteson","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2008.09.006_bib31","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2008.09.006_bib32","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2008.09.006_bib33","doi-asserted-by":"crossref","first-page":"923","DOI":"10.7326\/0003-4819-140-11-200406010-00014","article-title":"Observational studies of treatment effectiveness: some cautions","volume":"140","author":"Laupacis","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bone.2008.09.006_bib34","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1210\/jc.85.11.4118","article-title":"Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group","volume":"85","author":"Black","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2008.09.006_bib35","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/01.GME.0000123641.76105.B5","article-title":"Changes in bone density and turnover after alendronate or estrogen withdrawal","volume":"11","author":"Wasnich","year":"2004","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.bone.2008.09.006_bib36","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00198-007-0460-7","article-title":"Fracture risk remains reduced one year after discontinuation of risedronate","volume":"19","author":"Watts","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2008.09.006_bib37","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1359\/JBMR.040326","article-title":"Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension","volume":"19","author":"Ensrud","year":"2004","journal-title":"J. Bone Miner. Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328208007734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328208007734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T10:54:45Z","timestamp":1631876085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328208007734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S8756328208007734"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2008.09.006","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}